301156.SZ
美农生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 11.43
−2.64%Year over year
Reported trailing growth
- Revenue
- +26.1%
- EBITDA
- —
- EBIT
- +22.7%
- EPS
- +23.9%
- Free cash flow
- —
- Operating cash flow
- -53.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.1%
- EBITDA
- +9.1%
- EBIT
- +1.2%
- Net income
- +1.5%
- EPS
- -10.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026